Health ❯Healthcare ❯Clinical Trials

Drug Approval

FDA Approval Neurology Kisqali EMA FDA

FDA Approves VYKAT XR, First Therapy for Hyperphagia in Prader-Willi Syndrome

FDA Approves Ozempic to Reduce Kidney Disease Risks in Type 2 Diabetes Patients

FDA Approves Zepbound as First Medication for Obstructive Sleep Apnea in Adults with Obesity

FDA Expands Approval of Kisqali for Early-Stage Breast Cancer